Jennifer Allison

500 total citations
25 papers, 209 citations indexed

About

Jennifer Allison is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics. According to data from OpenAlex, Jennifer Allison has authored 25 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Economics and Econometrics. Recurrent topics in Jennifer Allison's work include Renal cell carcinoma treatment (7 papers), Renal and related cancers (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Jennifer Allison is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Renal and related cancers (5 papers) and Economic and Financial Impacts of Cancer (4 papers). Jennifer Allison collaborates with scholars based in United Kingdom, United States and France. Jennifer Allison's co-authors include Adrian S. Woolf, Rachel Belk, Dagan Jenkins, Maria Bitner‐Glindzicz, Sally Feather, Paul J.D. Winyard, Ambrose Gullett, Tung‐Tien Sun, Sue Malcolm and David F. Thomas and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Jennifer Allison

25 papers receiving 206 citations

Peers

Jennifer Allison
Rachel Belk United Kingdom
Scott Roberts United States
Michael P. Rimmer United Kingdom
Sara Hogan United States
Shahryar K. Kavoussi United States
Geoffrey Reid Australia
Jennifer Allison
Citations per year, relative to Jennifer Allison Jennifer Allison (= 1×) peers Saturnino Luján

Countries citing papers authored by Jennifer Allison

Since Specialization
Citations

This map shows the geographic impact of Jennifer Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Allison more than expected).

Fields of papers citing papers by Jennifer Allison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Allison. The network helps show where Jennifer Allison may publish in the future.

Co-authorship network of co-authors of Jennifer Allison

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Allison. A scholar is included among the top collaborators of Jennifer Allison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Allison. Jennifer Allison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2024). Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results. Clinical Genitourinary Cancer. 22(5). 102141–102141. 1 indexed citations
2.
Allison, Jennifer, Sam Wong, Helen Wong, et al.. (2023). Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis. Targeted Oncology. 18(4). 593–599. 1 indexed citations
3.
Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2023). Real-world treatment sequencing and outcomes for patients with advanced renal cell carcinoma treated with cabozantinib after first-line checkpoint inhibitor-based combination therapy: Results from the CARINA study.. Journal of Clinical Oncology. 41(16_suppl). e16512–e16512. 2 indexed citations
4.
Allison, Jennifer, et al.. (2023). QI initiative to reduce the number of inpatient falls in an acute hospital Trust. BMJ Open Quality. 12(1). e002102–e002102. 2 indexed citations
5.
Wysocka, Magdalena, Oskar Wysocki, Manon Pillai, et al.. (2023). Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy. Journal of Biomedical Informatics. 142. 104367–104367. 19 indexed citations
6.
Allison, Jennifer, Sam Wong, Helen Wong, et al.. (2022). Tivozanib (T) as first-line (1L) treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in North-West of England (NWE), UK.. Journal of Clinical Oncology. 40(6_suppl). 335–335. 1 indexed citations
7.
Allison, Jennifer, Xin Wang, Melissa Frizziero, et al.. (2022). The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases. Current Oncology. 29(7). 5110–5125. 1 indexed citations
8.
Allison, Jennifer, Natalie Charnley, Robert B. Stevenson, Tom Waddell, & Manon Pillai. (2021). Axitinib and avelumab (AA) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in the Northwest of England, United Kingdom.. Journal of Clinical Oncology. 39(6_suppl). 294–294. 2 indexed citations
9.
Allison, Jennifer, Richard W. Griffiths, Tom Waddell, & Manon Pillai. (2021). Ipilimumab and nivolumab (I+N) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world review in North West of England, United Kingdom.. Journal of Clinical Oncology. 39(6_suppl). 295–295. 1 indexed citations
10.
Jamal‐Hanjani, Mariam, Alastair Greystoke, Fiona Thistlethwaite, et al.. (2021). An open-label, multicenter phase I/IIa study evaluating the safety and clinical activity of clonal neoantigen reactive T cells in patients with advanced non-small cell lung cancer (CHIRON).. Journal of Clinical Oncology. 39(15_suppl). TPS9138–TPS9138. 3 indexed citations
11.
Ali, Bina, Deborah A. Fisher, Ted R. Miller, et al.. (2019). Trends in Drug Poisoning Deaths Among Adolescents and Young Adults in the United States, 2006–2015. Journal of Studies on Alcohol and Drugs. 80(2). 201–210. 19 indexed citations
12.
Ali, Bina, Bruce A. Lawrence, Ted R. Miller, & Jennifer Allison. (2019). Products and activities associated with non-fatal traumatic brain injuries in children and adolescents – United States 2010-2013. Brain Injury. 33(11). 1425–1429. 6 indexed citations
13.
Allison, Jennifer, et al.. (2019). What patient assessment skills are required by pharmacists prescribing systemic anti-cancer therapy? A consensus study. Journal of Oncology Pharmacy Practice. 25(8). 1933–1944. 6 indexed citations
14.
Ali, Bina, Bruce B. Lawrence, Ted R. Miller, David Swedler, & Jennifer Allison. (2019). Consumer Products Contributing to Fall Injuries in Children Aged <1 to 19 Years Treated in US Emergency Departments, 2010 to 2013: An Observational Study. Global Pediatric Health. 6. 2333794X18821941–2333794X18821941. 7 indexed citations
15.
Spicer, Rebecca S., et al.. (2018). Building the Child Safety Collaborative Innovation and Improvement Network: How does it work and what is it achieving?. Injury Prevention. 24(Suppl 1). i46–i51. 1 indexed citations
16.
Allison, Jennifer. (2011). Instrumental Evaluation of Pediatric Dysphagia: FEES Versus Videofluoroscopy. OpenSIUC (Southern Illinois University Carbondale). 1 indexed citations
17.
Allison, Jennifer & Evelyn S. Johnson. (2011). Identifying Struggling Readers in Middle School with ORF, Maze and Prior Year Assessment Data. Journal of Educational and Developmental Psychology. 1(1). 2 indexed citations
18.
Jenkins, Dagan, Maria Bitner‐Glindzicz, S Malcolm, et al.. (2006). Mutation analyses of Uroplakin II in children with renal tract malformations. Nephrology Dialysis Transplantation. 21(12). 3415–3421. 21 indexed citations
19.
Jenkins, Dagan, Maria Bitner‐Glindzicz, Sue Malcolm, et al.. (2005). De Novo Uroplakin IIIa Heterozygous Mutations Cause Human Renal Adysplasia Leading to Severe Kidney Failure. Journal of the American Society of Nephrology. 16(7). 2141–2149. 86 indexed citations
20.
Allison, Jennifer. (1990). Five ways to keep disputes out of court.. PubMed. 68(1). 166–8, 172. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026